PYYX
Pyxus International, Inc.3.1000
-0.1000-3.13%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q3 '26
Key Stats
Market Cap
76.28MP/E (TTM)
-Basic EPS (TTM)
-0.12Dividend Yield
0%Recent Filings
8-K
10-Q
10-Q
Q2 FY2026 results
Pyxus posted Q2 sales of $570.2M, up 0.7% y/y yet down 10.2% YTD to $1,079.0M from shipment timing, while gross profit climbed 16.4% y/y to $87.8M (15.4% margin from 13.3%) on Leaf segment volume and mix in Africa and South America. Operating income rose 41.5% y/y to $46.7M, but net loss narrowed to $(0.9)M or $(0.03) per diluted share from $(3.2)M or $(0.12), with EPS matching 25,806k shares (anti-dilutive RSUs excluded). Debt swelled seasonally to $1.4B including $908M notes payable, offset by $99M cash and $316M liquidity; no FCF as operating cash used $581M. Inventories ballooned to $1.1B for bigger Southern crops. Product liability claims shadow joint ventures.
8-K
Solid Q2, raised guidance
Pyxus International reported solid Q2 fiscal 2026 results on November 12, 2025, with sales at $570.2 million, gross margin expanding to 15.4% from 13.3%, and operating income up $13.7 million to $46.7 million. Adjusted EBITDA rose to $54.8 million. It raised full-year sales guidance to $2.4-$2.6 billion and tightened adjusted EBITDA to $215-$235 million. Larger crops boost inventory, yet steady demand persists.
8-K
Shareholders back Pyxus board, plan
Pyxus International held its 2025 annual shareholder meeting on August 14, electing seven directors—John S. Alphin, Jamie J. Ashton, Patrick J. Bartels, Jr., Robert D. George, Cynthia P. Moehring, J. Pieter Sikkel, and Richard J.C. Topping—for one-year terms, with votes for ranging from 18.96 million to 19.18 million amid 67,017 to 271,277 withheld. Shareholders ratified Deloitte & Touche LLP as auditors for the fiscal year ending March 31, 2026, with 20.63 million in favor, approved executive compensation on an advisory basis (19.13 million for), and endorsed the Amended and Restated 2020 Incentive Plan (18.62 million for). Strong support signals board continuity. Yet broker non-votes hit 1.47 million across proposals.
BTI
British American Tobacco Indus
57.29-0.45
CHUC
Charlie's Holdings, Inc.
0.18+0.01
MO
Altria Group, Inc.
59.33+0.24
PM
Philip Morris International Inc
157.95-0.46
PNXP
Pineapple Express Cannabis Comp
0.01+0.00
RLX
RLX Technology Inc.
2.37-0.03
TOBAF
TAAT Global Alternatives Inc.
0.04+0.00
TPB
Turning Point Brands, Inc.
110.86+1.25
UVV
Universal Corporation
54.49-0.21
XXII
22nd Century Group, Inc
1.05+0.09